Coinfection of hepatic cell lines with human immunodeficiency virus and hepatitis B virus leads to an increase in intracellular hepatitis B surface antigen

Journal of Virology

Volumn 84, Issue 12, 2010, Pages 5860-5867

  Iser, David M ^a,b   Warner, Nadia ^c   Revill, Peter A ^c   Solomon, Ajantha ^d   Wightman, Fiona ^d   Saleh, Suha ^d   Crane, Megan ^d   Cameron, Paul U ^b,d   Bowden, Scott ^c   Nguyen, Tin ^c   Pereira, Cândida F ^d,e,f   Desmond, Paul V ^a   Locarnini, Stephen A ^c   Lewin, Sharon R ^b,d,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ALFRED HOSPITAL   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e BURNET INSTITUTE   (Australia)

^f MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ENHANCED GREEN FLUORESCENT PROTEIN; MARAVIROC; NUCLEIC ACID; PLERIXAFOR; VIRUS DNA;

ARTICLE; CELL LINE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE CYCLE; LIVER CELL; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SOUTHERN BLOTTING; VESICULAR STOMATITIS VIRUS; VIRUS STRAIN; WESTERN BLOTTING;

CELL LINE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HIV INFECTIONS; HIV-1; HUMANS;

HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; VESICULAR STOMATITIS VIRUS;

EID: 77952680679     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02594-09     Document Type: Article

References (33)

1. Babu, C., K. Suwansrinon, G. Bren, A. Badley, and S. Rizza. 2009. HIV induces TRAIL sensitivity in hepatocytes. PLoS One 4:e4623.
2. Bacsi, A., P. Ebbeson, J. Szabo, Z. Beck, I. Andirko, E. Csoma, and F. Toth. 2001. Pseudotypes of vesicular stomatitis virus-bearing envelope antigens of certain HIV-1 strains permissively infect human syncytiotrophoblasts cultured in vitro: implications for in vivo infection of syncytiotrophoblasts by cell-free HIV-1. J. Med. Virol. 64:387-397.
3. Blackard, J., and K. Sherman. 2008. HCV/HIV co-infection: time to re-evaluate the role of HIV in the liver? J. Viral Hepat. 15:323-330. (Pubitemid 351473633)
4. Bock, C. T., H. L. Tillmann, J. Torresi, J. Klempnauer, S. Locarnini, M. P. Manns, and C. Trautwein. 2002. Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation. Gastroenterology 122:264-273.
5. Bruss, V., and D. Ganem. 1991. The role of envelope proteins in hepatitis B virus assembly. Proc. Natl. Acad. Sci. U. S. A. 88:1059-1063.
6. Cameron, P., P. Freudenthal, J. Barker, S. Gezelter, K. Inaba, and R. Steinman. 1992. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 257:383-387.
7. Cao, Y., D. Dieterich, P. Thomas, Y. Huang, M. Mirabile, and D. Ho. 1992. Identification and quantitation of HIV-1 in the liver of patients with AIDS. AIDS 6:65-70.
8. Cao, Y., A. Friedman-Kien, Y. Huang, X. Li, M. Mirabile, T. Moudgil, D. Zucker-Franklin, and D. Ho. 1990. CD4-independent, productive human immunodeficiency virus type 1 infection of hepatoma cell lines in vitro. J. Virol. 64:2553-2559.
9. + T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J. Virol. 79: 3038-3051.
10. Chisari, F. V., K. Klopchin, T. Moriyama, C. Pasquinelli, H. A. Dunsford, S. Sell, C. A. Pinkert, R. L. Brinster, and R. D. Palmiter. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145-1156. (Pubitemid 20024625)
11. Colin, J. F., D. Cazals-Hatem, M. A. Loriot, M. Martinot-Peignoux, B. N. Pham, A. Auperin, C. Degott, J. P. Benhamou, S. Erlinger, D. Valla, and P. Marcellin. 1999. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29:1306-1310. (Pubitemid 29168769)
12. Donzella, G., D. Schols, S. Lin, J. Este, K. Nagashima, P. Maddon, G. Allaway, T. Sakmar, G. Henson, E. De Clercq, and J. Moore. 1998. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat. Med. 4:72-77.
13. Dou, H., J. Morehead, J. Bradley, S. Gorantla, B. Ellison, J. Kingsley, L. Smith, W. Chao, G. Bentsman, D. Volsky, and H. Gendelman. 2006. Neuropathologic and neuroinflammatory activities of HIV-1-infected human astrocytes in murine brain. Glia 54:81-93. (Pubitemid 44078130)
14. Foo, N. C., B. Y. Ahn, X. Ma, W. Hyun, and T. S. Yen. 2002. Cellular vacuolization and apoptosis induced by hepatitis B virus large surface protein. Hepatology 36:1400-1407.
15. Gomez-Gonzalo, M., M. Carretero, J. Rullas, E. Lara-Pezzi, J. Aramburu, B. Berkhout, J. Alcami, and M. Lopez-Cabrera. 2001. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. J. Biol. Chem. 276:35435-35443.
16. Gripon, P., C. Diot, A. Corlu, and C. Guguen-Guillouzo. 1989. Regulation by dimethylsulfoxide, insulin, and corticosteroids of hepatitis B virus replication. J. Med. Virol. 28:193-199.
17. Jones, K. L., S. Sonza, and J. Mak. 2008. Primary T-lymphocytes rescue the replication of HIV-1 DIS RNA mutants in part by facilitating reverse transcription. Nucleic Acids Res. 36:1578-1588.
18. Ladner, S., M. Otto, S. Barker, K. Zaifert, G.-H. Wang, J. Guo, C. Seeger, and R. King. 1997. Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication. Antimicrob. Agents Chemother. 41:1715-1720.
19. Lambert, C., T. Doring, and R. Prange. 2007. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma2-adaptin. J. Virol. 81:9050-9060. (Pubitemid 47311448)
20. Liu, H.-S., M.-S. Jan, C.-K. Chou, P.-H. Chen, and N.-J. Ke. 1999. Is green fluorescent protein toxic to the living cells? Biochem. Biophys. Res. Commun. 260:712-717.
21. Locarnini, S. 2004. Molecular virology of hepatitis B virus. Semin. Liver Dis. 24:3-10.
22. Munshi, N., A. Balasubramanian, M. Koziel, R. K. Ganju, and J. E. Groopman. 2003. Hepatitis C and human immunodeficiency virus envelope proteins cooperatively induce hepatocytic apoptosis via an innocent bystander mechanism. J. Infect. Dis. 188:1192-1204.
23. Popov, S., E. Popova, M. Inoue, and G. Gottlinger. 2008. Human immunodeficiency virus type 1 gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid. J. Virol. 82:1389-1398.
24. Price, P., A. Mohamed, A. Zelent, A. Neurath, and G. Acs. 1988. Translational selection in the expression of the hepatitis B virus envelope proteins. DNA 7:417-422.
25. Seto, E., T. B. Yen, B. Peterlin, and J.-H. Ou. 1988. Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc. Natl. Acad. Sci. U. S. A. 85:8286-8290.
26. Su, I.-J., H.-C. Wang, H.-C. Wu, and W.-Y. Huang. 2008. Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection. J. Gastroenterol. Hepatol. 23:1169-1174.
27. Tacke, F., C. Liedtke, S. Bocklage, M. Manns, and C. Trautwein. 2005. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter. Gut 54:1309-1317. (Pubitemid 41192494)
28. Thio, C., E. Seaberg, R. J. Skolasky, J. Phair, B. Visscher, A. Munoz, D. Thomas, and the Multicenter AIDS Cohort Study. 2002. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360:1921-1926.
29. Wang, H.-C., H.-C. Wu, C.-F. Chen, N. Fausto, H.-Y. Lei, and I.-J. Su. 2003. Different types of ground glass hepatocytes in chronic Hepatitis B virus infection contain specific pre-S mutants that may induce endoplasmic reticulum stress. Am. J. Pathol. 163:2441-2449.
30. Warner, N., and S. Locarnini. 2008. The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 48:88-98. (Pubitemid 351975534)
31. Weber, J., J. Weberova, M. Carobene, M. Mirza, J. Martinez-Picado, P. Kazanjian, and M. Quinones-Mateu. 2006. Use of a novel assay based on intact recombinant viruses expressing green (EGFP) or red (DsRed2) fluorescent proteins to examine the contribution of pol and env genes to overall HIV-1 replicative fitness. J. Virol. Methods 136:102-117.
32. Xu, A., G. Jensen, and T. B. Yen. 1997. Activation of hepatitis B virus S promoter by the large surface protein via induction of stress in the endoplasmic reticulum. J. Virol. 71:7387-7392.
33. Xu, Z., and T. S. Yen. 1996. Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles. J. Virol. 70:133-140. (Pubitemid 126508778)